Reflections on the regulation of the Polypill

  • Lennart Forslund
  • Published 2009 in Nature Clinical Practice Cardiovascular Medicine


In a controversial article published in 2003, Wald and Law proposed that a fixed combination of a statin, a beta-blocker, an angiotensin-converting enzyme inhibitor, hydrochlorothiazide, folic acid and aspirin (the ‘Polypill’) could help to prevent cardiovascular disease.1 The authors estimated that administration of such treatment to all people older than… (More)
DOI: 10.1038/ncpcardio1416


  • Presentations referencing similar topics